LMAT

LeMaitre Vascular, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · lemaitre.com

$111.53

Mkt Cap $2.5B

52w Low $78.01 83.8% of range 52w High $118.01

50d MA $108.97 200d MA $92.95

P/E (TTM) 43.9x

EV/EBITDA 22.0x

P/B 6.5x

Debt/Equity 0.5x

ROE 14.7%

P/FCF 24.7x

RSI (14) —

ATR (14) —

Beta 0.67

50d MA $108.97

200d MA $92.95

Avg Volume 220.9K

About

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	0.67	0.68	+1.5%	91.38	+11.6%	+24.4%	+18.4%	+17.5%	+18.0%	+16.4%	—
Nov 6, 2025	AMC	0.56	0.62	+9.9%	85.60	-3.0%	+1.4%	+2.6%	+5.6%	+5.1%	+4.7%	—
Aug 5, 2025	AMC	0.57	0.60	+5.3%	85.60	+8.7%	+8.9%	+10.1%	+7.8%	+8.2%	+10.3%	—
May 1, 2025	AMC	0.50	0.48	-4.0%	90.24	-2.1%	-12.8%	-10.9%	-9.0%	-9.6%	-9.7%	—
Feb 27, 2025	AMC	0.49	0.49	+0.0%	99.91	-9.9%	-8.1%	-7.8%	-9.4%	-12.9%	-17.4%	—
Oct 31, 2024	AMC	0.44	0.49	+11.4%	88.39	+1.0%	+7.3%	+9.0%	+11.6%	+15.1%	+14.3%	—
Aug 1, 2024	AMC	0.47	0.52	+10.6%	86.25	+4.9%	-1.4%	-6.7%	-5.1%	-6.9%	-3.8%	—
May 2, 2024	AMC	0.39	0.44	+12.8%	66.77	+7.8%	+11.2%	+12.3%	+13.7%	+12.3%	+13.8%	—
Feb 27, 2024	AMC	0.36	0.38	+5.6%	62.11	+4.7%	+14.4%	+12.7%	+8.8%	+9.4%	+8.6%	—
Nov 1, 2023	AMC	0.30	0.33	+10.0%	47.82	+0.0%	-2.4%	+1.4%	+2.9%	+3.5%	+3.4%	—
Aug 1, 2023	AMC	0.32	0.36	+12.5%	62.82	+4.2%	+3.0%	-8.9%	-9.5%	-8.3%	-9.1%	—
May 2, 2023	AMC	0.25	0.27	+8.0%	54.75	+7.8%	+15.2%	+19.1%	+23.4%	+21.7%	+19.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 26	Citizens	Maintains	Market Outperform → Market Outperform	—	$91.38	$102.00	+11.6%	+24.4%	+18.4%	+17.5%	+18.0%	+16.4%
Feb 26	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$91.38	$102.00	+11.6%	+24.4%	+18.4%	+17.5%	+18.0%	+16.4%
Feb 26	Roth Capital	Maintains	Buy → Buy	—	$91.38	$102.00	+11.6%	+24.4%	+18.4%	+17.5%	+18.0%	+16.4%
Feb 26	Barrington Research	Maintains	Outperform → Outperform	—	$91.38	$102.00	+11.6%	+24.4%	+18.4%	+17.5%	+18.0%	+16.4%
Feb 20	Barrington Research	Maintains	Outperform → Outperform	—	$91.86	$92.25	+0.4%	+1.2%	-0.5%	-1.2%	-0.5%	+23.8%
Nov 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$85.60	$83.03	-3.0%	+1.4%	+2.6%	+5.6%	+5.1%	+4.7%
Oct 15	Barrington Research	Maintains	Outperform → Outperform	—	$87.38	$87.12	-0.3%	-0.1%	-0.6%	-0.9%	+0.7%	+2.7%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$92.29	$92.29	+0.0%	-2.6%	-4.9%	-8.3%	-8.8%	-7.4%
Aug 6	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$85.60	$93.03	+8.7%	+8.9%	+10.1%	+7.8%	+8.2%	+10.3%
Aug 6	Barrington Research	Upgrade	Market Perform → Outperform	—	$85.60	$93.03	+8.7%	+8.9%	+10.1%	+7.8%	+8.2%	+10.3%
Jul 22	Barrington Research	Maintains	Market Perform → Market Perform	—	$79.82	$80.24	+0.5%	+0.7%	+2.9%	+1.2%	+3.3%	+3.3%
Feb 28	Lake Street	Maintains	Buy → Buy	—	$99.91	$90.00	-9.9%	-8.1%	-7.8%	-9.4%	-12.9%	-17.4%
Feb 28	Citizens Capital Markets	Maintains	Buy → Buy	—	$99.91	$90.00	-9.9%	-8.1%	-7.8%	-9.4%	-12.9%	-17.4%
Feb 28	Barrington Research	Downgrade	Outperform → Market Perform	—	$99.91	$90.00	-9.9%	-8.1%	-7.8%	-9.4%	-12.9%	-17.4%
Nov 1	Oppenheimer	Maintains	Outperform → Outperform	—	$88.39	$89.25	+1.0%	+7.3%	+9.0%	+11.6%	+15.1%	+14.3%
Nov 1	Barrington Research	Maintains	Outperform → Outperform	—	$88.39	$89.25	+1.0%	+7.3%	+9.0%	+11.6%	+15.1%	+14.3%
Sep 20	Barrington Research	Maintains	Outperform → Outperform	—	$90.18	$90.18	+0.0%	-0.2%	+1.4%	+1.1%	-1.0%	+0.1%
Aug 20	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$85.53	$86.34	+0.9%	-0.2%	+1.1%	+0.7%	+7.2%	+6.1%
Aug 2	Barrington Research	Maintains	Outperform → Outperform	—	$86.25	$90.50	+4.9%	-1.4%	-6.7%	-5.1%	-6.9%	-3.8%
May 3	Barrington Research	Maintains	Outperform → Outperform	—	$66.77	$72.00	+7.8%	+11.2%	+12.3%	+13.7%	+12.3%	+13.8%
May 3	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$66.77	$72.00	+7.8%	+11.2%	+12.3%	+13.7%	+12.3%	+13.8%
Apr 26	Stifel	Upgrade	Hold → Buy	—	$62.99	$65.34	+3.7%	+3.9%	+5.2%	+2.9%	+6.0%	+6.0%
Feb 28	Barrington Research	Maintains	Outperform → Outperform	—	$62.11	$65.00	+4.7%	+14.4%	+12.7%	+8.8%	+9.4%	+8.6%
Aug 3	Jefferies	Downgrade	Buy → Hold	—	$64.70	$63.34	-2.1%	-11.6%	-12.1%	-11.0%	-11.7%	-11.8%
Aug 2	Lake Street	Maintains	Buy → Buy	—	$62.82	$65.47	+4.2%	+3.0%	-8.9%	-9.5%	-8.3%	-9.1%
Aug 2	Barrington Research	Maintains	Outperform → Outperform	—	$62.82	$65.47	+4.2%	+3.0%	-8.9%	-9.5%	-8.3%	-9.1%
May 3	Barrington Research	Upgrade	Market Perform → Outperform	—	$54.75	$59.00	+7.8%	+15.2%	+19.1%	+23.4%	+21.7%	+19.6%
Oct 28	Barrington Research	Downgrade	Outperform → Market Perform	—	$51.83	$46.65	-10.0%	-19.1%	-16.3%	-16.8%	-15.2%	-14.0%
Sep 16	Jefferies	Maintains	Buy → Buy	—	$57.48	$58.38	+1.6%	+1.2%	-1.3%	-4.0%	-6.0%	-4.0%
Aug 3	Roth Capital	Maintains	Neutral → Neutral	—	$54.71	$54.72	+0.0%	+2.3%	+1.1%	+3.8%	+5.7%	+4.6%
May 4	Roth Capital	Maintains	Neutral → Neutral	—	$51.46	$51.01	-0.9%	-0.3%	+0.8%	-0.8%	-1.1%	-5.5%
Feb 12	KeyBanc	Maintains	Sector Weight → Equal Weight	—	$47.53	$47.62	+0.2%	+3.4%	+2.2%	+1.7%	+2.0%	+3.5%
Oct 30	Roth Capital	Maintains	Neutral → Neutral	—	$35.54	$35.60	+0.2%	-8.6%	-4.4%	-1.8%	-3.1%	-2.5%
Jul 24	Canaccord Genuity	Maintains	Hold → Hold	—	$28.93	$31.99	+10.6%	+10.3%	+3.6%	+1.6%	+4.7%	+4.5%
Jul 24	Stifel	Maintains	Hold → Hold	—	$28.93	$31.99	+10.6%	+10.3%	+3.6%	+1.6%	+4.7%	+4.5%
May 4	Stifel	Maintains	Hold → Hold	—	$26.37	$25.83	-2.0%	-4.1%	-0.9%	-1.0%	-0.6%	+0.0%
Apr 14	Canaccord Genuity	Maintains	Hold → Hold	—	$26.94	$27.38	+1.6%	+3.8%	-0.3%	+3.2%	+9.5%	+3.3%
Apr 8	Sidoti & Co.	Maintains	Buy → Buy	—	$24.73	$25.22	+2.0%	+4.4%	+11.1%	+8.9%	+13.1%	+8.6%
Mar 16	Sidoti & Co.	Upgrade	Neutral → Buy	—	$24.45	$23.76	-2.8%	-9.7%	+3.8%	+2.6%	-3.1%	-12.5%
Oct 24	First Analysis	Downgrade	Strong Buy → Outperform	—	$36.00	$37.01	+2.8%	-4.5%	-2.9%	-2.3%	-0.9%	-0.8%
Oct 24	Lake Street	Upgrade	Hold → Buy	—	$36.00	$37.01	+2.8%	-4.5%	-2.9%	-2.3%	-0.9%	-0.8%
Oct 14	First Analysis	Upgrade	Outperform → Strong Buy	—	$31.33	$32.27	+3.0%	+3.4%	+7.8%	+8.3%	+10.8%	+11.9%
Jul 25	First Analysis	Upgrade	Neutral → Outperform	—	$33.40	$34.40	+3.0%	-1.9%	-2.4%	-1.8%	-2.2%	-0.9%
Oct 8	Canaccord Genuity	Maintains	Hold → Hold	—	$28.53	$29.04	+1.8%	-0.4%	-6.6%	-4.3%	-2.1%	-1.1%
Oct 8	Roth Capital	Maintains	Buy → Buy	—	$28.53	$29.04	+1.8%	-0.4%	-6.6%	-4.3%	-2.1%	-1.1%
Jul 9	Canaccord Genuity	Maintains	Hold → Hold	—	$36.73	$36.96	+0.6%	-2.0%	-1.2%	-0.8%	-0.4%	-0.5%
Jun 25	Lake Street	Maintains	Buy → Buy	—	$35.18	$35.62	+1.3%	+0.0%	+2.2%	-2.1%	-4.1%	-4.8%
Apr 26	Stifel	Downgrade	Buy → Hold	—	$39.01	$35.88	-8.0%	-17.1%	-19.3%	-19.4%	-16.1%	-14.3%
Apr 26	Stifel Nicolaus	Downgrade	Buy → Hold	—	$39.01	$35.88	-8.0%	-17.1%	-19.3%	-19.4%	-16.1%	-14.3%
Apr 26	Benchmark	Upgrade	Hold → Buy	—	$39.01	$35.88	-8.0%	-17.1%	-19.3%	-19.4%	-16.1%	-14.3%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

The board reduction from eight to seven members and planned executive transition suggest potential leadership restructuring at LendingMarket, which investors should monitor for implications on strategic direction and management continuity.

Apr 14

8-K

LeMaitre Vascular, Inc. -- 8-K Filing

LeMaitre Vascular filed standard forward-looking statement disclaimers and exhibits documentation with the SEC, providing no material updates to investor expectations regarding the vascular medical device company's operations or financial performance.

Feb 25

Data updated apr 25, 2026 7:24pm · Source: massive.com